Knowledge (XXG)

6-Pyruvoyltetrahydropterin synthase deficiency

Source 📝

252:
three histidine residues that form the metal-binding site in the substrate binding pocket: His 23,48 and 50. Residues Cys42, Glu133, and His89 are in close proximity to the binding pocket but are not binding it. These are thought to serve as proton donors and acceptors during catalysis. The cofactor bound can be either Mg2+ or Ni2+ (Protein Database). As previously mentioned it is involved in the biosynthesis of BH4 and catalyzes the transformation of 7,8-dihydroneopterin triphosphate into 6-pyruvoyl tetrahydropterin synthase. The kinetic values for this enzyme are KM = 8.1 μM and Vmax = 120 nmol/min/mg. The structure of
37: 314: 228: 160:. Response to treatment is variable and the long-term and functional outcome is unknown. To provide a basis for improving the understanding of the epidemiology, genotype–phenotype correlation and outcome of these diseases, their impact on the quality of life of patients, and for evaluating diagnostic and therapeutic strategies a patient registry was established by the noncommercial 251:
monomers form a 12-stranded antiparallel 𝛃-barrel by tight association between the N and C terminus of 2 adjacent subunits. The active enzyme complex is formed by two trimers in a head-to-head fashion. The active site is in between the trimer-trimer interface and has 3 monomers: A, A′, B. There are
348:
Taiwanese Chinese are more likely to get PTPS deficiency as the prevalence in Taiwanese Chinese is about 1/132,000 compared to white individuals at about 1/1,000,000. PTPS deficiency occurs most commonly in Asian countries and this makes sense because of the incidence of this disease in Taiwanese
885:
Blau N, Thony B, Cotton RGH, Hyland K. 2001. Disorders of tetrahydrobiopterin and related biogenic amines. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Vogelstein B, editors. The metabolic and molecular bases of inherited disease. New York: McGraw-Hill. pp
1888: 986: 971: 956: 1881: 256:
is unique and is different than other examples of antiparallel 𝛃-barrels. It is described as being formed by "a three-fold symmetrical arrangement of subunits". A similar 𝛃-barrel formation has been discovered in
1874: 161: 2024: 380:
from the diet was not working for other forms of HPA. This was attributed to a deficiency of tetrahydrobiopterin (BH4), a cofactor for PAH. The most common form of BH4 deficiency is due to
1086: 376:”. The foundations for dietary restrictions were laid down by George Jervis and Host Bickel which is still one of the best ways to treat PKU. However, this very practice of excluding 546:"A case of 6-pyruvoyl-tetrahydropterin synthase deficiency demonstrates a more significant correlation of l-Dopa dosage with serum prolactin levels than CSF homovanillic acid levels" 196:
is an intermediate in this cycle and is needed to convert 7,8 - dihydroneopterin triphosphate to 6-Pyruvoyltetrahydryobiopterin. 6-Pyruvoyltetrahydryobiopterin is converted into BH
876:
FollingIA. 1934. Uber Ausscheidung von Phenylbrenztraubensaure in den Harn als Stoffwechselanomalie in Verbindung mit Inbicillitat. Hoppe Seylers Z Physiol Chem 227:169.
1948: 1167: 1414: 1372: 1275: 1437: 1079: 1735: 1172: 180:
is a neurotransmitter which is also involved in movement. The absence of enough of this molecule causes the movement disorders in an affected individual.
372:
as the cause of a strange, musty odor from the urine of two Norwegian children. Further research by Penrose in 1935 lead to the coining of the term, “
834:
Liu, Tze-Tze; Chiang, Szu-Hui; Wu, Sheu-Jen; Hsiao, Kwang-Jen (November 2001). "Tetrahydrobiopterin-deficient hyperphenylalaninemia in the Chinese".
2014: 1776: 1072: 2019: 1972: 1099: 775:
Parge, H.E.; Arvai, A.S.; Tainer, J.A. (1995-02-07). "Human Ckshs2 Atomic Structure: A Role for ITS Hexameric Assembly in Cell Cycle Control".
1931: 1750: 1745: 1667: 1503: 1001: 397: 385: 381: 357: 262: 253: 248: 244: 240: 213: 193: 285:
PTPS deficiency can usually be detected by the same screening test used for PKU, because both disorders result in elevated levels of
1255: 274: 455: 1041: 810: 1754: 583:
Escalante-Acosta, Bruno Alfonso; Ramos-Brizuela, Luz Maria; Vargas-Robles, Hilda; Rubio-Guerra, Alberto Francisco (2010-09-29).
1918: 811:"6-pyruvoyl-tetrahydropterin synthase deficiency | Genetic and Rare Diseases Information Center (GARD) – an NCATS Program" 289:. This test is known as the Guthrie test and is done on babies a few days after birth. Another diagnostic method is to measure 1993: 1988: 1558: 671:"Three-dimensional structure of 6-pyruvoyl tetrahydropterin synthase, an enzyme involved in tetrahydrobiopterin biosynthesis" 58: 1639: 1803: 1771: 1442: 153: 1845: 1177: 231:
This image depicts the pathway for the synthesis if tetrahydrobiopterin, a very important cofactor in the human body.
1897: 1835: 1814: 1486: 1095: 365: 1840: 1730: 1447: 1419: 1187: 294: 442:
Thöny B; Blau N (1997). "Mutations in the GTP cyclohydrolase I and 6-pyruvoyl-tetrahydropterin synthase genes".
1134: 1129: 1012: 544:
Ogawa, Atsushi; Kanazawa, Masaki; Takayanagi, Masaki; Kitani, Yutaka; Shintaku, Haruo; Kohno, Yoichi (2008).
1905: 1866: 1635: 1300: 141: 1955: 1926: 1629: 1498: 1280: 1784: 1219: 361: 62: 54: 1052: 417: 1645: 1595: 1350: 1107: 269:
is that the formation of the latter is metal induced and reversible. The PTPS trimer is similar to a
88:, and marked diurnal fluctuation. Other reported clinical features include difficulty in swallowing, 81: 728:"Serine 19 of Human 6-Pyruvoyltetrahydropterin Synthase Is Phosphorylated by cGMP Protein Kinase II" 1850: 1701: 1590: 1250: 1205: 1182: 990: 485:
Pearl PL; Taylor JL; Trzcinski S; Sokohl A (May 2007). "The pediatric neurotransmitter disorders".
157: 149: 137: 124:, and sudden death have also been reported. Patients with mild phenotypes may deteriorate if given 1585: 1508: 1475: 1144: 512: 467: 369: 125: 1855: 1327: 965: 919: 859: 851: 792: 757: 749: 708: 690: 639: 616: 565: 504: 459: 298: 89: 1810: 1692: 1673: 1490: 1465: 909: 843: 784: 739: 698: 682: 606: 596: 557: 496: 451: 133: 1798: 1793: 1625: 1545: 1345: 1149: 373: 270: 117: 36: 1064: 1705: 1659: 1470: 1409: 1139: 686: 611: 584: 487: 995: 847: 703: 670: 313: 227: 2008: 1740: 1599: 1532: 1387: 377: 286: 221: 209: 188:
To understand how the absence of this enzyme affects the body, we must look at the BH
726:
Scherer-Oppliger, Tanja; Leimbacher, Walter; Blau, Nenad; Thöny, Beat (1999-10-29).
516: 1576: 1392: 1322: 1317: 1260: 561: 471: 129: 101: 97: 74: 1017: 1725: 1568: 585:"Is tetrahydrobiopterin a therapeutic option in diabetic hypertensive patients?" 200:(Tetrahydrobiopterin), but since it stops at 6-Pyruvoyltetrahydrobiopterin no BH 1819: 1788: 1580: 1457: 1429: 1197: 1111: 980: 635: 388:
was discovered and it was learned that PKU causes HPA but not all HPA is PKU.
360:
deficiency is not necessarily its own disease. It shares history with PKU and
93: 70: 855: 753: 744: 727: 694: 569: 500: 1715: 1364: 1360: 1309: 1295: 545: 290: 247:
monomer folds into a sequential four-stranded, antiparallel 𝛃-sheet. Three
113: 66: 923: 863: 761: 669:
Nar, H.; Huber, R.; Heizmann, C.W.; Thöny, B.; Bürgisser, D. (March 1994).
643: 620: 508: 144:. Treatment options include substitution with neurotransmitter precursors ( 30:
Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency
796: 788: 712: 463: 1710: 1655: 1621: 1609: 1536: 1523: 1271: 1229: 1047: 177: 145: 105: 85: 78: 948: 1901: 1613: 1337: 1267: 1242: 1233: 1159: 914: 897: 601: 456:
10.1002/(SICI)1098-1004(1997)10:1<11::AID-HUMU2>3.0.CO;2-P
1914: 1401: 1120: 975: 960: 173: 121: 109: 172:
Movement disorders mentioned are caused by the inability to produce
368:, a physician studying metabolic diseases, identified an excess of 226: 162:
International Working Group on Neurotransmitter Related Disorders
1036: 1006: 266: 258: 1870: 1068: 349:
Chinese being significantly higher than any other population.
308: 236:
Structure and function of 6-Pyruvoyltetrahydropterin Synthase
44:
This condition is inherited in an autosomal recessive manner
418:"Orphanet: 6 pyruvoyl tetrahydropterin synthase deficiency" 132:, which can interfere with a salvage pathway through which 530: 216:
deficiency share some similar symptoms. However, since BH
53:
is an autosomal recessive disorder that causes malignant
324: 2025:
Vitamin, coenzyme, and cofactor metabolism disorders
938: 634:
Regier, Debra S; Greene, Carol L (January 5, 2017).
220:
is needed for much more than just the metabolism of
61:. It is a recessive disorder that is accompanied by 1981: 1965: 1940: 1912: 1828: 1770: 1700: 1690: 1654: 1608: 1567: 1544: 1531: 1521: 1484: 1456: 1428: 1400: 1385: 1359: 1336: 1308: 1293: 1241: 1227: 1218: 1196: 1158: 1119: 1106: 1027: 942: 26: 21: 293:levels in urine and to measure neurotransmitters 65:. Commonly reported symptoms are initial truncal 1949:Pantothenate kinase-associated neurodegeneration 1168:3-hydroxy-3-methylglutaryl-CoA lyase deficiency 1042:6-pyruvoyl-tetrahydropterin synthase deficiency 1554:6-Pyruvoyltetrahydropterin synthase deficiency 51:6-Pyruvoyltetrahydropterin synthase deficiency 22:6-Pyruvoyltetrahydropterin synthase deficiency 1882: 1080: 273:and is hypothesized to serve as a tunnel for 8: 1438:2-Methylbutyryl-CoA dehydrogenase deficiency 1736:Carbamoyl phosphate synthetase I deficiency 1173:3-Methylcrotonyl-CoA carboxylase deficiency 898:"Genetics of Phenylketonuria: Then and Now" 1889: 1875: 1867: 1697: 1541: 1528: 1397: 1305: 1238: 1224: 1116: 1087: 1073: 1065: 939: 35: 18: 913: 743: 702: 610: 600: 243:is a hexamer of identical subunits. The 1415:Isobutyryl-CoA dehydrogenase deficiency 409: 1973:Familial isolated vitamin E deficiency 636:"Phenylalanine Hydroxylase Deficiency" 1932:Holocarboxylase synthetase deficiency 1751:Ornithine transcarbamylase deficiency 1746:N-Acetylglutamate synthase deficiency 638:. University of Washington, Seattle. 7: 1668:Dopamine beta hydroxylase deficiency 664: 662: 660: 224:, there are other symptoms as well. 1504:Methylmalonyl-CoA mutase deficiency 398:6-pyruvoyltetrahydropterin synthase 687:10.1002/j.1460-2075.1994.tb06377.x 212:. This is the reason that PKU and 14: 1256:Glutathione synthetase deficiency 589:Integrated Blood Pressure Control 312: 2015:Amino acid metabolism disorders 732:Journal of Biological Chemistry 1994:Molybdenum cofactor deficiency 1989:Tetrahydrobiopterin deficiency 1559:Tetrahydrobiopterin deficiency 562:10.1016/j.braindev.2007.05.011 59:tetrahydrobiopterin deficiency 1: 2020:Autosomal recessive disorders 1804:Lysinuric protein intolerance 1178:3-Methylglutaconic aciduria 1 896:Blau, Nenad (February 2016). 848:10.1016/s0009-8981(01)00669-6 275:dihydroneopterin triphosphate 1443:Beta-ketothiolase deficiency 154:monoamine oxidase inhibitors 1846:Ethylmalonic encephalopathy 2041: 1836:2-Hydroxyglutaric aciduria 1815:Oculocerebrorenal syndrome 208:affects the metabolism of 204:is made. The absence of BH 69:, subsequent appendicular 1841:Aminoacylase 1 deficiency 1731:Argininosuccinic aciduria 1640:Hermansky–Pudlak syndrome 1448:Maple syrup urine disease 1420:Maple syrup urine disease 1188:Maple syrup urine disease 815:rarediseases.info.nih.gov 556:(1). Elsevier BV: 82–85. 295:5-hydroxyindolacetic acid 261:, the difference between 43: 34: 1130:Glutaric acidemia type 1 745:10.1074/jbc.274.44.31341 501:10.1177/0883073807302619 1636:Oculocutaneous albinism 142:dihydrofolate reductase 1956:Methylmalonic acidemia 1927:Biotinidase deficiency 1755:translocase deficiency 1499:Methylmalonic acidemia 1281:Glycine encephalopathy 321:This section is empty. 232: 1785:Solute carrier family 1100:amino acid metabolism 550:Brain and Development 362:hyperphenylalaninemia 230: 63:hyperphenylalaninemia 55:hyperphenylalaninemia 1646:Waardenburg syndrome 1596:Tyrosinemia type III 1351:Prolidase deficiency 836:Clinica Chimica Acta 1982:Nonvitamin cofactor 1898:Metabolic disorders 1851:Fumarase deficiency 1591:Tyrosinemia type II 1251:D-Glyceric acidemia 1206:Hypertryptophanemia 1183:Isovaleric acidemia 789:10.2210/pdb1cks/pdb 738:(44): 31341–31348. 192:synthesis pathway. 158:tetrahydrobiopterin 150:5-hydroxytryptophan 138:tetrahydrobiopterin 1586:Tyrosinemia type I 1509:Propionic acidemia 1476:Hypermethioninemia 1145:Pipecolic acidemia 1028:External resources 915:10.1002/humu.22980 602:10.2147/ibpc.s7479 233: 136:is converted into 126:folate antagonists 2002: 2001: 1904:, coenzymes, and 1864: 1863: 1856:Trimethylaminuria 1766: 1765: 1762: 1761: 1686: 1685: 1682: 1681: 1517: 1516: 1381: 1380: 1328:Urocanic aciduria 1289: 1288: 1214: 1213: 1062: 1061: 341: 340: 299:homovanillic acid 90:oculogyric crises 48: 47: 16:Medical condition 2032: 1891: 1884: 1877: 1868: 1811:Fanconi syndrome 1698: 1674:Brunner syndrome 1542: 1529: 1466:Cystathioninuria 1398: 1306: 1239: 1225: 1117: 1089: 1082: 1075: 1066: 940: 928: 927: 917: 893: 887: 883: 877: 874: 868: 867: 842:(1–2): 157–169. 831: 825: 824: 822: 821: 807: 801: 800: 783:(5132): 387–95. 772: 766: 765: 747: 723: 717: 716: 706: 681:(6): 1255–1262. 675:The EMBO Journal 666: 655: 654: 652: 650: 631: 625: 624: 614: 604: 580: 574: 573: 541: 535: 534: 527: 521: 520: 482: 476: 475: 439: 433: 432: 430: 428: 414: 336: 333: 323:You can help by 316: 309: 134:dihydrobiopterin 39: 19: 2040: 2039: 2035: 2034: 2033: 2031: 2030: 2029: 2005: 2004: 2003: 1998: 1977: 1961: 1936: 1908: 1895: 1865: 1860: 1824: 1799:Iminoglycinuria 1794:Hartnup disease 1775: 1758: 1708: 1678: 1650: 1626:Ocular albinism 1604: 1563: 1546:Phenylketonuria 1513: 1480: 1452: 1424: 1391: 1377: 1355: 1346:Hyperprolinemia 1332: 1301:α-ketoglutarate 1299: 1285: 1276:GAMT deficiency 1210: 1192: 1154: 1150:Saccharopinuria 1123:/straight chain 1102: 1093: 1063: 1058: 1057: 1023: 1022: 951: 937: 932: 931: 895: 894: 890: 884: 880: 875: 871: 833: 832: 828: 819: 817: 809: 808: 804: 774: 773: 769: 725: 724: 720: 668: 667: 658: 648: 646: 633: 632: 628: 582: 581: 577: 543: 542: 538: 529: 528: 524: 484: 483: 479: 441: 440: 436: 426: 424: 416: 415: 411: 406: 394: 374:phenylketonuria 366:Asbjørn Følling 355: 346: 337: 331: 328: 307: 283: 238: 219: 207: 203: 199: 191: 186: 170: 118:hypersalivation 17: 12: 11: 5: 2038: 2036: 2028: 2027: 2022: 2017: 2007: 2006: 2000: 1999: 1997: 1996: 1991: 1985: 1983: 1979: 1978: 1976: 1975: 1969: 1967: 1963: 1962: 1960: 1959: 1952: 1944: 1942: 1938: 1937: 1935: 1934: 1929: 1923: 1921: 1910: 1909: 1896: 1894: 1893: 1886: 1879: 1871: 1862: 1861: 1859: 1858: 1853: 1848: 1843: 1838: 1832: 1830: 1826: 1825: 1823: 1822: 1817: 1807: 1806: 1801: 1796: 1791: 1781: 1779: 1768: 1767: 1764: 1763: 1760: 1759: 1757: 1748: 1743: 1738: 1733: 1728: 1723: 1721: 1720: 1719: 1706:Hyperammonemia 1695: 1688: 1687: 1684: 1683: 1680: 1679: 1677: 1676: 1670: 1664: 1662: 1660:Norepinephrine 1652: 1651: 1649: 1648: 1643: 1633: 1618: 1616: 1606: 1605: 1603: 1602: 1593: 1588: 1583: 1573: 1571: 1565: 1564: 1562: 1561: 1556: 1550: 1548: 1539: 1526: 1519: 1518: 1515: 1514: 1512: 1511: 1506: 1501: 1495: 1493: 1482: 1481: 1479: 1478: 1473: 1471:Homocystinuria 1468: 1462: 1460: 1454: 1453: 1451: 1450: 1445: 1440: 1434: 1432: 1426: 1425: 1423: 1422: 1417: 1412: 1410:Hypervalinemia 1406: 1404: 1395: 1383: 1382: 1379: 1378: 1376: 1375: 1369: 1367: 1357: 1356: 1354: 1353: 1348: 1342: 1340: 1334: 1333: 1331: 1330: 1325: 1320: 1314: 1312: 1303: 1291: 1290: 1287: 1286: 1284: 1283: 1278: 1264: 1263: 1258: 1253: 1247: 1245: 1236: 1222: 1216: 1215: 1212: 1211: 1209: 1208: 1202: 1200: 1194: 1193: 1191: 1190: 1185: 1180: 1175: 1170: 1164: 1162: 1156: 1155: 1153: 1152: 1147: 1142: 1140:Hyperlysinemia 1137: 1132: 1126: 1124: 1114: 1104: 1103: 1094: 1092: 1091: 1084: 1077: 1069: 1060: 1059: 1056: 1055: 1044: 1032: 1031: 1029: 1025: 1024: 1021: 1020: 1009: 998: 983: 968: 952: 947: 946: 944: 943:Classification 936: 935:External links 933: 930: 929: 908:(6): 508–515. 902:Human Mutation 888: 878: 869: 826: 802: 767: 718: 656: 626: 575: 536: 522: 495:(5): 606–616. 488:J Child Neurol 477: 434: 408: 407: 405: 402: 401: 400: 393: 390: 370:phenylpyruvate 354: 351: 345: 342: 339: 338: 319: 317: 306: 303: 282: 279: 237: 234: 217: 205: 201: 197: 189: 185: 182: 169: 166: 84:, generalized 46: 45: 41: 40: 32: 31: 28: 24: 23: 15: 13: 10: 9: 6: 4: 3: 2: 2037: 2026: 2023: 2021: 2018: 2016: 2013: 2012: 2010: 1995: 1992: 1990: 1987: 1986: 1984: 1980: 1974: 1971: 1970: 1968: 1966:Other vitamin 1964: 1957: 1953: 1950: 1946: 1945: 1943: 1939: 1933: 1930: 1928: 1925: 1924: 1922: 1920: 1916: 1911: 1907: 1903: 1899: 1892: 1887: 1885: 1880: 1878: 1873: 1872: 1869: 1857: 1854: 1852: 1849: 1847: 1844: 1842: 1839: 1837: 1834: 1833: 1831: 1827: 1821: 1818: 1816: 1812: 1809: 1808: 1805: 1802: 1800: 1797: 1795: 1792: 1790: 1786: 1783: 1782: 1780: 1778: 1773: 1769: 1756: 1752: 1749: 1747: 1744: 1742: 1741:Citrullinemia 1739: 1737: 1734: 1732: 1729: 1727: 1724: 1722: 1717: 1714: 1713: 1712: 1707: 1703: 1699: 1696: 1694: 1689: 1675: 1671: 1669: 1666: 1665: 1663: 1661: 1657: 1653: 1647: 1644: 1641: 1637: 1634: 1631: 1627: 1623: 1620: 1619: 1617: 1615: 1611: 1607: 1601: 1600:Hawkinsinuria 1597: 1594: 1592: 1589: 1587: 1584: 1582: 1578: 1575: 1574: 1572: 1570: 1566: 1560: 1557: 1555: 1552: 1551: 1549: 1547: 1543: 1540: 1538: 1534: 1533:Phenylalanine 1530: 1527: 1525: 1520: 1510: 1507: 1505: 1502: 1500: 1497: 1496: 1494: 1492: 1488: 1483: 1477: 1474: 1472: 1469: 1467: 1464: 1463: 1461: 1459: 1455: 1449: 1446: 1444: 1441: 1439: 1436: 1435: 1433: 1431: 1427: 1421: 1418: 1416: 1413: 1411: 1408: 1407: 1405: 1403: 1399: 1396: 1394: 1389: 1388:propionyl-CoA 1384: 1374: 1371: 1370: 1368: 1366: 1362: 1358: 1352: 1349: 1347: 1344: 1343: 1341: 1339: 1335: 1329: 1326: 1324: 1321: 1319: 1316: 1315: 1313: 1311: 1307: 1304: 1302: 1297: 1292: 1282: 1279: 1277: 1273: 1269: 1266: 1265: 1262: 1259: 1257: 1254: 1252: 1249: 1248: 1246: 1244: 1240: 1237: 1235: 1231: 1226: 1223: 1221: 1217: 1207: 1204: 1203: 1201: 1199: 1195: 1189: 1186: 1184: 1181: 1179: 1176: 1174: 1171: 1169: 1166: 1165: 1163: 1161: 1157: 1151: 1148: 1146: 1143: 1141: 1138: 1136: 1133: 1131: 1128: 1127: 1125: 1122: 1118: 1115: 1113: 1109: 1105: 1101: 1097: 1090: 1085: 1083: 1078: 1076: 1071: 1070: 1067: 1054: 1050: 1049: 1045: 1043: 1039: 1038: 1034: 1033: 1030: 1026: 1019: 1015: 1014: 1010: 1008: 1004: 1003: 999: 997: 993: 992: 988: 984: 982: 978: 977: 973: 969: 967: 963: 962: 958: 954: 953: 950: 945: 941: 934: 925: 921: 916: 911: 907: 903: 899: 892: 889: 882: 879: 873: 870: 865: 861: 857: 853: 849: 845: 841: 837: 830: 827: 816: 812: 806: 803: 798: 794: 790: 786: 782: 778: 771: 768: 763: 759: 755: 751: 746: 741: 737: 733: 729: 722: 719: 714: 710: 705: 700: 696: 692: 688: 684: 680: 676: 672: 665: 663: 661: 657: 645: 641: 637: 630: 627: 622: 618: 613: 608: 603: 598: 594: 590: 586: 579: 576: 571: 567: 563: 559: 555: 551: 547: 540: 537: 532: 526: 523: 518: 514: 510: 506: 502: 498: 494: 490: 489: 481: 478: 473: 469: 465: 461: 457: 453: 449: 445: 438: 435: 423: 422:www.orpha.net 419: 413: 410: 403: 399: 396: 395: 391: 389: 387: 383: 379: 378:phenylalanine 375: 371: 367: 363: 359: 352: 350: 343: 335: 326: 322: 318: 315: 311: 310: 304: 302: 300: 297:(5-HIAA) and 296: 292: 288: 287:Phenylalanine 280: 278: 276: 272: 268: 264: 260: 255: 250: 246: 242: 235: 229: 225: 223: 222:Phenylalanine 215: 211: 210:Phenylalanine 195: 183: 181: 179: 175: 167: 165: 163: 159: 155: 151: 147: 143: 139: 135: 131: 127: 123: 119: 115: 111: 107: 103: 99: 95: 91: 87: 83: 80: 76: 72: 68: 64: 60: 56: 52: 42: 38: 33: 29: 25: 20: 1693:oxaloacetate 1577:Alkaptonuria 1553: 1393:succinyl-CoA 1323:Histidinemia 1318:Carnosinemia 1261:Sarcosinemia 1096:Inborn error 1046: 1035: 1011: 1000: 985: 970: 955: 905: 901: 891: 881: 872: 839: 835: 829: 818:. Retrieved 814: 805: 780: 776: 770: 735: 731: 721: 678: 674: 649:November 27, 647:. Retrieved 629: 592: 588: 578: 553: 549: 539: 525: 492: 486: 480: 450:(1): 11–20. 447: 443: 437: 425:. Retrieved 421: 412: 356: 347: 344:Epidemiology 329: 325:adding to it 320: 284: 239: 187: 171: 168:Presentation 130:methotrexate 120:, rash with 102:hyperthermia 98:irritability 75:bradykinesia 50: 49: 1726:Argininemia 1569:Tyrosinemia 384:. Later on 27:Other names 2009:Categories 1820:Cystinosis 1789:Cystinuria 1702:Urea cycle 1581:Ochronosis 1458:Methionine 1430:Isoleucine 1198:Tryptophan 1112:acetyl-CoA 886:1725–1776. 820:2018-12-09 595:: 125–32. 444:Hum. Mutat 404:References 94:somnolence 71:hypertonia 1906:cofactors 1777:IE of RTT 1772:Transport 1716:aspartate 1672:reverse: 1365:glutamine 1361:Glutamate 1310:Histidine 1296:glutamate 856:0009-8981 754:0021-9258 695:0261-4189 570:0387-7604 305:Treatment 291:Pteridine 281:Diagnosis 184:Mechanism 114:athetosis 67:hypotonia 1902:vitamins 1711:arginine 1656:Tyrosine 1622:Albinism 1610:Tyrosine 1537:tyrosine 1524:fumarate 1485:General 1272:Creatine 1230:pyruvate 1048:Orphanet 924:26919687 864:11694255 762:10531334 644:20301677 621:21949628 517:10689202 509:17690069 392:See also 364:(HPA) . 332:May 2023 178:Dopamine 164:(iNTD). 146:levodopa 128:such as 106:seizures 86:dystonia 82:rigidity 79:cogwheel 1941:Other B 1614:Melanin 1338:Proline 1268:Glycine 1243:Glycine 1234:citrate 1160:Leucine 1018:C535325 966:5C59.01 797:8211159 777:Science 713:8137809 612:3172060 472:9085242 464:9222755 427:16 June 353:History 301:(HVA). 57:due to 1915:Biotin 1402:Valine 1373:SSADHD 1135:type 2 1121:Lysine 1007:261640 922:  862:  854:  795:  760:  752:  711:  704:394939 701:  693:  642:  619:  609:  568:  531:"Home" 515:  507:  470:  462:  174:L-Dopa 156:, and 122:eczema 110:Chorea 104:, and 1954:B12 ( 1829:Other 996:270.1 981:E70.1 513:S2CID 468:S2CID 271:porin 1947:B5 ( 1037:GARD 1013:MeSH 1002:OMIM 991:9-CM 920:PMID 860:PMID 852:ISSN 793:PMID 758:PMID 750:ISSN 709:PMID 691:ISSN 651:2023 640:PMID 617:PMID 566:ISSN 505:PMID 460:PMID 429:2019 386:PTPS 382:PTPS 358:PTPS 267:CKS2 265:and 263:PTPS 259:CKS2 254:PTPS 249:PTPS 245:PTPS 241:PTPS 214:PTPS 194:PTPS 140:via 1919:MCD 1913:B7 1900:of 1098:of 987:ICD 972:ICD 957:ICD 910:doi 844:doi 840:313 785:doi 781:262 740:doi 736:274 699:PMC 683:doi 607:PMC 597:doi 558:doi 497:doi 452:doi 327:. 152:), 2011:: 1813:: 1787:: 1691:G→ 1624:: 1522:G→ 1491:OA 1487:BC 1386:G→ 1294:G→ 1274:: 1228:G→ 1053:13 1051:: 1040:: 1016:: 1005:: 994:: 979:: 976:10 964:: 961:11 918:. 906:37 904:. 900:. 858:. 850:. 838:. 813:. 791:. 779:. 756:. 748:. 734:. 730:. 707:. 697:. 689:. 679:13 677:. 673:. 659:^ 615:. 605:. 591:. 587:. 564:. 554:30 552:. 548:. 511:. 503:. 493:22 491:. 466:. 458:. 448:10 446:. 420:. 277:. 176:. 148:, 116:, 112:, 108:. 100:, 96:, 92:, 77:, 73:, 1958:) 1951:) 1917:/ 1890:e 1883:t 1876:v 1774:/ 1753:/ 1718:) 1709:( 1704:/ 1658:→ 1642:) 1638:( 1632:) 1630:1 1628:( 1612:→ 1598:/ 1579:/ 1535:/ 1489:/ 1390:→ 1363:/ 1298:→ 1270:→ 1232:→ 1220:G 1110:→ 1108:K 1088:e 1081:t 1074:v 989:- 974:- 959:- 949:D 926:. 912:: 866:. 846:: 823:. 799:. 787:: 764:. 742:: 715:. 685:: 653:. 623:. 599:: 593:3 572:. 560:: 533:. 519:. 499:: 474:. 454:: 431:. 334:) 330:( 218:4 206:4 202:4 198:4 190:4

Index


hyperphenylalaninemia
tetrahydrobiopterin deficiency
hyperphenylalaninemia
hypotonia
hypertonia
bradykinesia
cogwheel
rigidity
dystonia
oculogyric crises
somnolence
irritability
hyperthermia
seizures
Chorea
athetosis
hypersalivation
eczema
folate antagonists
methotrexate
dihydrobiopterin
tetrahydrobiopterin
dihydrofolate reductase
levodopa
5-hydroxytryptophan
monoamine oxidase inhibitors
tetrahydrobiopterin
International Working Group on Neurotransmitter Related Disorders
L-Dopa

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.